XML 178 R44.htm IDEA: XBRL DOCUMENT v3.24.4
Expenses and Other Non-Operating (Income) Expense, Net (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Expenses And Other Non Operating Income Expense Net [Abstract]    
Schedule of Sales and Marketing Expenses  

Sales and marketing expenses

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

(as restated)

 

 

(as restated)

 

Advertisement and publicity expenses

 

$

144,584

 

 

 

635,166

 

Employee salaries and benefits

 

 

1,371,468

 

 

 

1,788,941

 

Consultancy charges

 

 

1,602,332

 

 

 

1,538,729

 

Share-based payments to employees

 

 

2,649,012

 

 

 

375,721

 

Share-based payments to related parties

 

 

963,858

 

 

 

 

Total

 

 

6,731,254

 

 

 

4,338,557

 

Schedule of General and Administrative Expenses  

General and administrative expenses

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

(as restated)

 

 

(as restated)

 

IT expenses

 

$

1,135,355

 

 

 

1,066,708

 

Legal and professional expenses

 

 

2,274,891

 

 

 

5,569,989

 

Business development expenses

 

 

777,161

 

 

 

7,136,168

 

Employee salaries and benefits

 

 

4,340,558

 

 

 

3,506,501

 

Consultancy charges

 

 

3,472,170

 

 

 

8,223,297

 

Share-based payments to employees

 

 

2,543,621

 

 

 

1,739,294

 

Share-based payments to related parties

 

 

2,083,647

 

 

 

39,501,701

 

Share-based payments for consultancy

 

 

485,080

 

 

 

18,417,816

 

Other

 

 

874,045

 

 

 

1,479,026

 

Total

 

 

17,986,528

 

 

 

86,640,500

 

Schedule of Other Non-operating (income)/ expenses, net

 

 

Six months ended

June 30, 2024

$

 

 

Six months ended

June 30, 2023

$

 

Foreign exchange (gain) loss

 

108,224

 

 

327,383

 

R&D credits

 

 

 

(496,448

)

Other, net

 

(408

)

 

(2,686)

 

Total

 

107,816

 

 

(171,751

)

Other non-operating (income) expense, net

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

(as restated)

 

 

(as restated)

 

Foreign exchange loss

 

$

375,298

 

 

 

194,524

 

R&D credits

 

 

(497,978

)

 

 

(467,563

)

Other, net

 

 

(2,686

)

 

 

16,380

 

Total

 

 

125,366

 

 

 

(256,659

)